Filter Search


Europe


Location Summary Deadline
Germany Medicines With The Active Ingredient Lactulose (atc: A06ad11) 2026-06-06
Germany Medicines With The Active Ingredient Flecainide (atc: C01bc04) 2026-06-06
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-06-06
Germany Pharmaceutical Discount Contracts According To § 130a Para. 8 Sgb V Within The Framework Of Open House Procedures 2026-06-06
Germany The Tender Involves The Conclusion Of A Non-exclusive Discount Agreement According To § 130a Paragraph 8 Sgb V For The Active Ingredient Lebrikizumab, Atc D11ah10, For The Period From January 1, 2026, To December 31, 2027. The Dak-gesundheit Intends To Co 2026-06-06
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-06-06
Germany Aripiprazole (n05ax12), Without Tablets, Orodispersible Tablets, Oral Solutions 2026-06-06
Germany Calcipotriol & Betamethasone (d05ax22), Without Ointment And Gel 2026-06-06
Latvia The Creation Of A Dynamic Procurement System For The Construction Of Heating Networks Up To 2dn80 (including) 2026-06-06
Germany Paliperidone (n05ax13), Nur Trevicta 2026-06-06
Whats app